New Key Statistics Module, Z-Score and F-Score
NAS:ALLO Key Ratios
| Market Cap $ M | 504.87 |
| Enterprise Value $ M | 217.47 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.09 |
| Price/Sales | 2,925.55 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.82 |
| Beneish M-Score | -3.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 17.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.76 |
| EV-to-EBITDA | -0.80 |
| PEG | -- |
| Shares Outstanding M | 170.85 |
| Net Margin (%) | -451,632.31 |
| Operating Margin % | -438,347.69 |
| Pre-tax Margin (%) | -451,632.31 |
| Quick Ratio | 12.80 |
| Current Ratio | 12.80 |
| ROA % (ttm) | -42.43 |
| ROE % (ttm) | -52.95 |
| ROIC % (ttm) | -121.31 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.35 |
ALLO Number of Guru Trades
ALLO Volume of Guru Trades
Gurus Latest Trades with NAS:ALLO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ALLO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Allogene Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ALLO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers